Eli Lilly and Company (LLY · NYSE)

LLY · MARKET VIEW

Market view · as of Sep 7, 2026

Revenue (TTM)
$79.67B
+47.7% YoY
Gross margin
83.4%
EPS (latest q)
$8.38
vs $6.01 est · beat
52-wk position
77.0%
-10.2% vs 52w high · -2.9% 1mo

Price (last ~year)

Eli Lilly and Company (LLY) maintains a $1.02 trillion market capitalization, supported by a 47.7% year-over-year revenue increase and $79.67 billion in trailing twelve-month revenue. For the quarter ending June 30, 2026, the company generated $22.97 billion in revenue and reported earnings of $8.38 per share, exceeding analyst estimates. The firm operates with an 83.4% gross margin and a 1.3x debt-to-EBITDA ratio, reflecting its current financial scale and operational efficiency.

Valuation

Market cap
$1.02T
P/E
38.61
PEG
1.122
P/B
30.51
P/S
12.87
EV/EBITDA
25.88
Beta
0.502
Analyst target
$1315.56

Quality & returns

Gross margin
83.4%
Operating margin
54.2%
Profit margin
33.5%
ROE
102.3%
ROA
20.4%

Price movement

Last
$1149.36
1-month
-2.9%
3-month
+1.3%
RSI (14)
43
vs SMA200
+8.4%
52-wk position
77.0% -10.2% vs high

Quarterly trajectory

Revenue by quarter (oldest → newest)

QuarterRevenueOp incomeNet incomeEBITDA
2026-06-30$22.97B$8.98B$7.09B$9.25B
2026-03-31$19.80B$8.85B$7.40B$9.69B
2025-12-31$19.29B$8.78B$6.64B$8.39B
2025-09-30$17.60B$8.39B$5.58B$7.88B

Recent news

Sources this view read

  • fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
  • filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
  • earnings Reported earnings history (Alpha Vantage EARNINGS)
  • prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)

Other snapshots